(Reuters) -Amarin Corp Plc said on Monday it would cut its workforce by 40%, as the drugmaker’s fish-oil derived heart drug faces stiff competition from generic rivals in the United …
Shore News Network is a free website that does not use paywalls or charge for access to original, breaking news content. In order to provide this free service, we rely on advertisements. Please support our journalism by disabling your ad blocker for this website.